Applied pharmacology in percutaneous coronary intervention: You can't fight mother nature
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29202
Abstract: Differential outcomes based on target vessel diameter persist in the era of second generation drug eluting stents. These differences are mainly driven by need for target vessel revascularization without appreciable differences in hard atherosclerotic cardiovascular… read more here.
Keywords: applied pharmacology; pharmacology percutaneous; pharmacology; percutaneous coronary ... See more keywords
Pharmacology before, during and after percutaneous coronary intervention
Sign Up to like & getrecommendations! Published in 2020 at "Heart"
DOI: 10.1136/heartjnl-2019-315090
Abstract: ### Learning objectives Coronary intervention initiates thrombin generation through endothelial damage and plaque disruption. The subsequent thrombotic risk1 can persist for several weeks and dissipates, but not disappear, after stent endothelialisation. Adjunctive antithrombotic pharmacology, therefore,… read more here.
Keywords: pharmacology percutaneous; pharmacology; percutaneous coronary; coronary intervention ... See more keywords